20/20 Biolabs
$0.2130
2
-$0.02-6.78%Friday 20:00
-$0.00-1.36%Friday 22:20After hours
Statistics
Day High
0.2119
Day Low
0.2105
52W High
50
52W Low
0.2101
Volume
2,724
Avg. Volume
-
Mkt Cap
2.72M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q1 2026
Q2 2026
Next
-0.28
-0.22
-0.16
-0.1
Expected EPS
-0.14
Actual EPS
N/A
Financials
-182.84%Profit Margin
Unprofitable2.05MRevenue
-3.74MNet Income
Analyst Ratings
$5.00Average Price Target
The highest estimate is 5.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
Show More
CEO
Jonathan Cohen
Employees
14
Country
United States
ISIN
US90138K1016
Listings
0 Comments
Share your thoughts
FAQs
What is 20/20 Biolabs stock price today?▼
The current price of AIDX is $0.21 USD — it has decreased by -6.78% in the past 24 hours. Watch 20/20 Biolabs stock price performance more closely on the chart.
What is 20/20 Biolabs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange 20/20 Biolabs stocks are traded under the ticker AIDX.
What is 20/20 Biolabs market cap?▼
Today 20/20 Biolabs has the market capitalization of 2.72M
When is the next 20/20 Biolabs earnings date?▼
20/20 Biolabs is going to release the next earnings report on December 2, 2026.
What were 20/20 Biolabs earnings last quarter?▼
AIDX earnings for the last quarter are -0.26 USD per share, whereas the estimation was -0.12 USD resulting in a -116.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is 20/20 Biolabs revenue for the last year?▼
20/20 Biolabs revenue for the last year amounts to 2.05M USD.
What is 20/20 Biolabs net income for the last year?▼
AIDX net income for the last year is -3.74M USD.
How many employees does 20/20 Biolabs have?▼
As of November 2, 2026, the company has 14 employees.
In which sector is 20/20 Biolabs located?▼
20/20 Biolabs operates in the Health & Wellness sector.
When did 20/20 Biolabs complete a stock split?▼
20/20 Biolabs has not had any recent stock splits.
Where is 20/20 Biolabs headquartered?▼
20/20 Biolabs is headquartered in ROCKVILLE, United States.